Immunovant Inc (IMVT) FY2025Q1 Earning Prediction

08/06 04:00:00

Immunovant Inc (IMVT) is set to release its earnings performance on 08/06 04:00:00 in trading. Consensus forecasts predict a revenue of 79.32M and an earnings per share (EPS) of -0.52 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!

Estimate

Actual

Surprise

Revenue-

79.32M

EPSMISS

-0.52

-0.60

-15.38%

Earnings Surprise Analysis

The chart displays the extent of earnings surprises and corresponding stock price movements for each earnings event.

Revenue

EPS

IMVT Transcript

Immunovant, Inc. (IMVT) Q2 2025 Earnings Call Transcript

Unknown11-12

The earnings call summary indicates a mixed sentiment. While there are positive aspects like potential market opportunities and a strong capitalization, concerns arise from litigation uncertainties, lack of clear guidance, and competitive pressures. The Q&A reveals cautious optimism but lacks concrete data to support strong positive sentiment. Given the market cap, the overall sentiment is neutral, suggesting limited short-term stock price movement.

Immunovant, Inc. (IMVT) Q2 2026 Earnings Call Transcript

Positive11-10

The earnings call summary indicates a positive outlook with strong financial performance, optimistic product development updates, a solid market strategy, and shareholder return plans. The Q&A section reveals management's confidence in their competitive positioning and strategic initiatives, despite some litigation uncertainties. Considering the company's market cap and the overall positive sentiment, the stock is likely to see a positive movement of 2% to 8%.

Immunovant, Inc. (IMVT) CEO Pete Salzmann on Q4 2022 Results - Earnings Call Transcript

Positive6-9

The earnings call highlights strong market research favoring batoclimab for TED, a dose-dependent efficacy in trials, and a strategic regulatory approach. The Q&A reveals confidence in batoclimab's potential despite previous mixed results, with a clear enrolment strategy and safety measures. The market cap suggests moderate volatility, supporting a positive outlook for stock price movement.

Immunovant, Inc. (IMVT) CEO Pete Salzmann on Q1 2022 Results - Earnings Call Transcript

Neutral8-9

IMVT Report

Immunovant, Inc. 10-Q

10-Q

2025-02-06

Immunovant, Inc. 10-Q

10-Q

2024-11-07

Immunovant, Inc. 10-Q

10-Q

2024-08-06

Immunovant, Inc. 10-K

10-K

2024-05-29

Frequently Asked Questions

What is the Immunovant Inc FY2025Q1 Earnings Release Date and Time?

Immunovant Inc (IMVT) is scheduled to release its FY2025Q1 earnings report onAug 6, 2024, (approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.

What Are the Consensus Forecasts for Immunovant Inc FY2025Q1 Revenue and EPS?

Analysts' consensus predicts 79.32M in revenue and an EPS of -0.52 for Immunovant Inc's FY2025Q1.

What Does Intellectia's AI Predict for Immunovant Inc FY2025Q1 Earnings?

Intellectia's exclusive AI algorithms forecast a forImmunovant Inc's FY2025Q1 earnings, with a prediction date of Aug 6, 2024. Immunovant Inc

How Can I Use This Earnings Prediction to Trade IMVT Stock?

Leverage Intellectia's AI forecast to position trades ahead of theAug 6, 2024 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.

How Accurate Is Intellectia's AI for Earnings Predictions Like Immunovant Inc FY2025Q1?

Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.

How does AI Earnings Prediction generate its forecasts?

AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!

When are the predictions available, and how often are they updated?

Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.

Can I use AI Earnings Prediction for all types of stocks?

Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!